IVZ Financial Statements & Analysis
Complete financial statements for IVZ including income statement, balance sheet, and cash flow statement. Analyze IVZ's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
58
Neutral
Poor (0-40)Neutral (40-60)Good (60-100)
Income Statement
Revenue
6.1% ↑
Net Income
899.6% ↑
Gross Margin
-4.8% ↓
Operating Margin
280.3% ↑
Balance Sheet
Current Ratio
147.9% ↑
Debt to Equity
-16.4% ↑
Asset Turnover
13.7% ↑
Cash Flow
Operating Cash Flow
-8.5% ↓
Net Cash Flow
-187.6% ↓
Free Cash Flow
-1.4% ↓
Cash Flow to Debt
9.6% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2023 | 2024 | Change | Impact |
|---|---|---|---|---|
| Revenue | 5.72B | 6.07B | 6.1% | |
| Gross Profit | 2.01B | 2.03B | 1.1% | |
| Operating Income | -434800000 | 832.10M | 291.4% | |
| Net Income | -96900000 | 774.80M | 899.6% | |
| EPS | -0.73 | 1.18 | 261.6% | |
| EBITDA | 1.13B | 1.24B | 9.9% | |
| Gross Margin | 35.08% | 33.41% | 4.8% | |
| Operating Margin | -7.61% | 13.72% | 280.3% | |
| Net Income Margin | -1.70% | 12.77% | 853.4% | |
| R&D Expenses | 0 | 0 | 0.0% |
Income Statement Full Table
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 6.07B | 5.72B | 6.05B | 6.89B | 6.15B |
| Gross Profit | 2.03B | 2.01B | 2.44B | 2.83B | 2.39B |
| Operating Income | 832.10M | -434800000 | 1.32B | 1.79B | 920.40M |
| Net Income | 774.80M | -96900000 | 920.70M | 1.63B | 761.60M |
| EPS | 1.18 | -0.73 | 1.5 | 3.01 | 1.14 |
| EBITDA | 1.24B | 1.13B | 1.53B | 2.80B | 1.40B |
| Gross Margin | 33.41% | 35.08% | 40.30% | 41.10% | 38.89% |
| Operating Margin | 13.72% | -7.61% | 21.78% | 25.94% | 14.98% |
| Net Income Margin | 12.77% | -1.70% | 15.22% | 23.64% | 12.39% |
| R&D Expenses | 0 | 0 | 0 | 0 | 0 |